These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31941991)

  • 1. Recombinant human thrombomodulin attenuated sepsis severity in a non-surgical preterm mouse model.
    Ashina M; Fujioka K; Nishida K; Okubo S; Ikuta T; Shinohara M; Iijima K
    Sci Rep; 2020 Jan; 10(1):333. PubMed ID: 31941991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis.
    Ogawa Y; Yamakawa K; Ogura H; Kiguchi T; Mohri T; Nakamori Y; Kuwagata Y; Shimazu T; Hamasaki T; Fujimi S
    J Trauma Acute Care Surg; 2012 May; 72(5):1150-7. PubMed ID: 22673239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Ohara S; Sato M; Hosoya M
    Nephrol Dial Transplant; 2015 Jun; 30(6):969-77. PubMed ID: 25694534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release.
    Akatsuka M; Masuda Y; Tatsumi H; Yamakage M
    PLoS One; 2020; 15(1):e0228093. PubMed ID: 31971961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
    Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin therapy for hyperglycemia in neonatal sepsis using a preterm mouse model.
    Miyauchi H; Fujioka K; Okubo S; Nishida K; Ashina M; Ikuta T; Okata Y; Maeda K; Iijima K; Bitoh Y
    Pediatr Int; 2020 May; 62(5):581-586. PubMed ID: 31885143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
    Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
    Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries.
    Goto T; Kudo D; Uchimido R; Hayakawa M; Yamakawa K; Abe T; Shiraishi A; Kushimoto S
    Crit Care; 2022 May; 26(1):145. PubMed ID: 35590381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis.
    Yamakawa K; Murao S; Aihara M
    Thromb Haemost; 2019 Jan; 119(1):56-65. PubMed ID: 30597500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Human Thrombomodulin Has Additive Effects in Septic Patients Undergoing Continuous Hemodiafiltration Due to Intestinal Perforation.
    Kono H; Hosomura N; Amemiya H; Kawaida H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D
    Shock; 2021 Sep; 56(3):374-383. PubMed ID: 33595258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yamada H; Kumagai K; Uemura A; Yuki S
    Biosci Biotechnol Biochem; 2020 Mar; 84(3):455-462. PubMed ID: 31738665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Role of an Initial Low-Dose Septic Challenge against Lethal Sepsis in Neonatal Mice: A Pilot Study.
    Nakasone R; Ashina M; Kido T; Miyauchi H; Saito M; Inoue S; Shinohara M; Nozu K; Fujioka K
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-1 deficiency promotes severity of sepsis in a non-surgical preterm mouse model.
    Fujioka K; Kalish F; Zhao H; Wong RJ; Stevenson DK
    Pediatr Res; 2018 Jul; 84(1):139-145. PubMed ID: 29795214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Human-Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients With Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset.
    Yoshihiro S; Sakuraya M; Hayakawa M; Ono K; Hirata A; Takaba A; Kawamura N; Tsutsui T; Yoshida K; Hashimoto Y
    Shock; 2019 Feb; 51(2):174-179. PubMed ID: 29596106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Thrombomodulin Modulates Murine Colitis Possibly via High-Mobility Group Box 1 Protein Inhibition.
    Ueda T; Higashiyama M; Narimatsu K; Yasutake Y; Kurihara C; Okada Y; Watanabe C; Yoshikawa K; Maruta K; Komoto S; Tomita K; Nagao S; Hokari R; Miura S
    Digestion; 2015; 92(2):108-19. PubMed ID: 26302768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.